Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endocrine and Neuroendocrine Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT04068896
What this trial is testing

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy

Who this might be right for
Pancreatic CancerMetastatic Castration-resistant Prostate CancerBladder Cancer+8 more
NGM Biopharmaceuticals, Inc 89
Testing effectiveness (Phase 2)Study completedNCT03012620
What this trial is testing

Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types

Who this might be right for
SarcomaOvarian NeoplasmCentral Nervous System Neoplasm+4 more
UNICANCER 334
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Early research (Phase 1)Study completedNCT04774952
What this trial is testing

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

Who this might be right for
Solid Tumors
Revolution Medicines, Inc. 58
Early research (Phase 1)Study completedNCT03629756
What this trial is testing

Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckBreast Cancer+9 more
Arcus Biosciences, Inc. 48
Testing effectiveness (Phase 2)Looking for participantsNCT07749586
What this trial is testing

Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Arvinas Inc. 499
Early research (Phase 1)UnknownNCT02970786
What this trial is testing

Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans

Who this might be right for
Neuroendocrine CarcinomaBreast CancerOvarian Cancer
Rigshospitalet, Denmark 10
Early research (Phase 1)Study completedNCT01935453
What this trial is testing

A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer

Who this might be right for
MelanomaLiver CancerPancreatic Cancer+1 more
OrienGene Biotechnology Ltd. 18
Not applicableLooking for participantsNCT07808164
What this trial is testing

ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort

Who this might be right for
HCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)Gastric Carcinoma+5 more
Tam Anh Research Institute 162
Not applicableLooking for participantsNCT00830557
What this trial is testing

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Who this might be right for
Islet Cell TumorPancreatic CancerPancreatic Disease+5 more
Mayo Clinic 20,000
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Not applicableLooking for participantsNCT06344507
What this trial is testing

Iconographic Registry of Pancreatobiliary Endoscopy Procedures

Who this might be right for
Pancreas NeoplasmCancer of PancreasPancreatitis+1 more
IRCCS San Raffaele 12,000
Not applicableEnrolling By InvitationNCT07182175
What this trial is testing

Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors

Who this might be right for
Primary AldosteronismAdrenal TumorCushing s Syndrome+1 more
Peking University First Hospital 150
Not applicableLooking for participantsNCT04498767
What this trial is testing

Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)

Who this might be right for
Gynecologic CancerSkin CancerHead and Neck Cancer+12 more
European Organisation for Research and Treatment of Cancer - EORTC 200
Early research (Phase 1)Ended earlyNCT02313012
What this trial is testing

Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors

Who this might be right for
Neoplasm Metastasis
Celgene 19
Testing effectiveness (Phase 2)Study completedNCT00121628
What this trial is testing

A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer
Amgen 184
Testing effectiveness (Phase 2)Study completedNCT00095836
What this trial is testing

Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

Who this might be right for
Head and Neck Cancer
Massachusetts General Hospital 27
Testing effectiveness (Phase 2)Ended earlyNCT01149434
What this trial is testing

Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers

Who this might be right for
CancerNeuroendocrineOvarian Cancer+1 more
University of Utah 19
Early research (Phase 1)Study completedNCT03689192
What this trial is testing

Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung CancerUrothelial CarcinomaMalignant Melanoma+5 more
Herlev Hospital 13
Next Page